Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03216499
Title HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

glioblastoma

Therapies

PT2385

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.